Han ML, et al. - Researchers sought the safety and efficacy of bariatric surgery in patients with hepatitis C virus (HCV) infection. For this purpose, they reviewed charts identifying 47 bariatric patients that suffered from HCV infection between 2000 and 2016. They recruited bariatric surgical patients with non-alcoholic steatohepatitis (NASH) and without NASH (non-NASH) as comparative groups. Patients in HCV(+) group were frequently females, and were of older age, lower BMI, and waist circumference than both NASH and non-NASH groups. They observed higher liver function tests and incidence of metabolic syndrome in both HCV(+) and NASH groups than non-NASH group. Compared to the NASH group, the HCV(+) group had lower uric acid and albumin level. Outcomes revealed no influence of HCV co-existence on the outcome of bariatric surgery. However, continuous monitoring of the liver function is indicated in these patients.